|
|
|
|
Lannett To Submit New Drug Application For Morphine Sulfate Products
Lannett Company, Inc.(NYSE AMEX: LCI) today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products to the U.S. Food and Drug Administration (FDA) at the end of the month. The company expects the FDA to review its...
|
|
|
Lannett to Submit New Drug Application for Morphine Sulfate Products
- Lannett Company, Inc.(NYSE AMEX: LCI) today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products to the U.S. Food and Drug Administration (FDA) at the end of the month. The company expects the FDA to review...
|
|
|
Lannett Company plans to submit its NDA for Morphine Sulfate products to FDA
Lannett Company, Inc.(NYSE AMEX: LCI) today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products to the U.S. Food and Drug Administration (FDA) at the end of the month. The company expects the FDA to review its...
|
|
|
Lannett to Submit New Drug Application for Morphine Sulfate Products
Lannett Company, Inc.(NYSE AMEX: LCI) today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products to the U.S. Food and Drug Administration (FDA) at the end of the month. The company expects the FDA to review its...
|
|
|
Lannett to Submit New Drug Application for Morphine Sulfate Products
PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc.(NYSE AMEX: LCI) today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products to the U.S. Food and Drug Administration (FDA) at the end of the month. The...
|
|
|
January 2010 Briefing - Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for January 2010.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most...
|
|
|
Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 1
COLUMBUS, Ohio, Jan.26 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the New Drug Application (NDA) approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 30mL and 120mL bottles as of January 25th, 2010 by the Food and Drug...
|
|
|
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain
Approval is part of Agency's unapproved drugs initiative SILVER SPRING, Md., Jan.26 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic...
|
|
|
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain
Approval is part of Agencys unapproved drugs initiative Silver Spring, MD, USA | January 26, 2010 | The U.S.Food and Drug Administration approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid...
|
|
|
Morphine Sulfate Solution Approved
TUESDAY, Jan.26 (HealthDay News) -- Morphine Sulfate Oral Solution has been approved by the U.S. Food and Drug Administration to treat acute and chronic pain. Sanctioned doses are 100 milligrams per 5 mL and 20 milligrams per 1 mL, the agency said...
|
|
|
US FDA approves Morphine Sulfate oral solution to treat pain in opioid-tolerant patients
The US Food and Drug Administration approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients.This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.
|
|
|
Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 1
Pharmacy Article 1/26/10 - Roxane Laboratories, Inc.Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) COLUMBUS, Ohio, Jan. 26 /PRwire/ Roxane Laboratories, Inc. announced today the New Drug...
|
|
|
FDA approves the NDA of Roxane Laboratories' Morphine Sulfate Oral Solution CII
Roxane Laboratories, Inc.announced today the New Drug Application (NDA) approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 30mL and 120mL bottles as of January 25th, 2010 by the Food and Drug Administration. This product is indicated...
|
|
|
1/26/10 - FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain
Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain - January 27, 2010 Pharmacy Article Approval is part of Agency's unapproved drugs initiative SILVER SPRING, Md., Jan.26 /PRwire-USwire/ The U.S. Food and Drug Administration...
|
|
|
FDA approves oral pain relief solution for opioid-tolerant patients
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic PainApproval is part of Agency's unapproved drugs initiative The U.S.Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate...
|
|
|
Medical News: FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
The U.S.Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams...
|
|
|
Medical News: FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
The U.S.Food and Drug Administration approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1...
|
|
|
FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
The U.S.Food and Drug Administration approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1...
|
|
|
FDA approves Morphine Sulfate Oral Solution
The US Food and Drug Administration approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients.This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.
|
|
|
1/26/10 - FDA approves widely-used morphine formulation
WASHINGTON-The Food and Drug Administration says it has confirmed the safety of a widely-used formulation of morphine that was previously unapproved.The agency approved Roxane Laboratories' Morphine Sulfate oral solution for patients with moderate to...
|
|
|
Morphine Sulfate Solution Approved
_ Morphine Sulfate Solution Approved.
|
|
|
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain
_ FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain.
|
|
|
Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 1
COLUMBUS, Ohio Roxane Laboratories', Inc.Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) is the only FDA approved Morphine Sulfate Oral Solution CII available at this concentration. Roxane Laboratories, Inc. has sufficient supply to...
|
|
|
Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL)
Roxane Laboratories, Inc.announced today the New Drug Application (NDA) approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 30mL and 120mL bottles as of January 25th, 2010 by the Food and Drug Administration. Roxane Laboratories, Inc....
|
|
|
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain
Approval is part of Agency's unapproved drugs initiative SILVER SPRING, Md., Jan.26 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic...
|
